John Matthew Wesner

Title: John Matthew Wesner: Innovator in Cell Therapy

Introduction

John Matthew Wesner is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cell therapy, particularly through his innovative approaches to genetically engineering T cells. His work is pivotal in advancing therapeutic compositions that can potentially transform treatment methodologies.

Latest Patents

Wesner holds a patent for a process titled "Process for generating therapeutic compositions of engineered cells." This patent outlines methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. The methods include steps for incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells through transduction or transfection, and cultivating the cells under conditions that promote proliferation and/or expansion. Notably, the incubation and cultivation can be performed in the presence of recombinant IL-2, making the process efficient and reliable for producing genetically engineered T cells with a high degree of success. He has 1 patent to his name.

Career Highlights

Wesner is currently associated with Juno Therapeutics GmbH, where he continues to push the boundaries of cell therapy research. His work at the company has been instrumental in developing innovative solutions that address complex medical challenges.

Collaborations

Wesner collaborates with notable colleagues, including Sarah Y Lee and Pascal Beauchesne. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries in the field of cell therapy.

Conclusion

John Matthew Wesner's contributions to the field of cell therapy through his innovative patent and collaborative efforts highlight his role as a key inventor in advancing medical science. His work continues to inspire future innovations in therapeutic applications.